Hill's Just Walked Away From Private Label Pet Food. Here's the Shelf Space That Creates.

Hill's Pet Nutrition exited its private label pet food business, a move that cost the company 2% of its organic sales growth in Q2.

The decision and what it cost

Hill's posted $1.2 billion in net sales for the second quarter of 2026, up 3.4% year-over-year. Organic sales grew 2.1%, but that figure includes a negative 2% impact from the company's exit from private label. Operating profit increased 2% to $269 million, while the operating profit margin declined 40 basis points to 22.5%.

Science Diet dog food also softened. Noel Wallace, Colgate-Palmolive's CEO, told investors the brand "grew in all segments across the business that we're focused on, except for Science Diet dog, where we've talked about the migration to small pets and large pets certainly deteriorating in terms of their ownership."

The growth came from e-commerce and omnichannel activations for Prescription Diet. Hill's reported strong performance from online-only retailers and Amazon Prime Day. The company's international business delivered mid-single-digit growth.

Who this squeezes and who it helps

If you stocked a private label line Hill's was manufacturing, or if Science Diet dog was a meaningful part of your premium set, you're facing a gap. The volume Hill's walked away from is real shelf space and real margin dollars.

Competitors with retail distribution, Purina Pro Plan, Blue Buffalo, Nutro, the regional premium lines your distributor keeps pitching, are positioned to absorb it. The question is whether you let them walk in or whether you use the reset to rebalance margin against velocity. A brand that wants that space will offer better terms now than it will after it's already back on shelves across your market.

If your reorder calendar runs on calls like this one, subscribe to PetRetailNews.

For emerging brands trying to land independent distribution, Hill's pullback is a concrete opening. A store that watched its Science Diet dog velocity flatten is more open to a new premium line this month than it was last quarter. The pitch is simpler: you're not asking them to cut an incumbent, you're asking them to fill a gap they're already looking at.

Our read: the margin protection move tells you what Hill's actually optimized for

Hill's exited private label manufacturing and absorbed the sales hit. Science Diet dog slowed on what Wallace described as a structural trend, fewer large dogs, more small pets, which is a headwind the company can't merchandise its way out of.

What that means for you: Hill's growth is coming from channels you don't control, vet clinics (Prescription Diet), Amazon, online-only retailers, and international markets. The company said it plans to invest further in advertising in the second half of 2026, but the growth drivers Wallace named don't point back to your aisle.

If Science Diet dog was a meaningful part of your premium set, watch whether Hill's spends to defend it or lets it drift. The ad dollars are going where the growth already is.

The consequence, not the summary

Hill's exited private label manufacturing and Science Diet dog softened. That's real shelf space in stores that haven't changed their set recently. If you're one of those stores, you're deciding what fills it. If you're a brand trying to land independent doors, you're deciding whether to pitch those stores now or wait until someone else already did.

The window is open. The rep from the brand that wants that space is deciding when to call.

← Back to the Newsdesk